Publication & Citation Trends
Publications
0 total
The Prevalence of CD146 Expression in Breast Cancer Subtypes and Its Relation to Outcome OA
Cited by 23
Semantic Scholar
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer OA
Cited by 187
Semantic Scholar
GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease. OA
Cited by 27
Semantic Scholar
The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer OA
Cited by 15
Semantic Scholar
Cell-free DNA mutations as biomarkers in breast cancer patients receiving tamoxifen OA
Cited by 32
Semantic Scholar
Sensitivity to systemic therapy for metastatic breast cancer in CHEK2 1100delC mutation carriers OA
Cited by 10
Semantic Scholar
Evaluation of the ability of adjuvant tamoxifen‐benefit gene signatures to predict outcome of hormone‐naive estrogen receptor‐positive breast cancer patients treated with tamoxifen in the advanced setting OA
Cited by 17
Semantic Scholar
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer OA
Cited by 137
Semantic Scholar
Research Topics
Protease and Inhibitor Mechanisms
(16)
Estrogen and related hormone effects
(12)
Cell Adhesion Molecules Research
(12)
Breast Cancer Treatment Studies
(11)
Epigenetics and DNA Methylation
(11)
Affiliations
South Australia Pathology
Mount Sinai Hospital
Erasmus MC
Cancer Genomics Centre
Erasmus MC Cancer Institute